News | January 10, 2024
Tata 1mg and Vitonnix UK get into an exclusive partnership in India
Launch innovative vitamin sublingual sprays
Launch innovative vitamin sublingual sprays
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Medway setup a state-of-the-art Heart Institute in Chennai
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Marks remarkable acceleration in innovation using AI technology
Subscribe To Our Newsletter & Stay Updated
